Company Executive Sells 4,981 Shares in Insider Sale

An insider sale has recently been reported involving Christopher F Dekker, the Executive Vice President, General Counsel, and Secretary of $BC, who sold 4,981 shares of the company at an estimated value of $435,239. This transaction, disclosed through a recent SEC filing, represented about 11.1% of their total holdings in this particular class of stock, leaving them with 39,740 shares remaining in their possession.

Over the past six months, $BC insiders have engaged in three instances of trading the company’s stock on the open market, with all three transactions constituting sales. These sales included David M Foulkes, the Chief Executive Officer, offloading 38,266 shares for approximately $3,312,304, and Nancy E Cooper divesting 233 shares for around $14,939. Thus, the recent sale by Christopher F Dekker is just one of several insider transactions that have taken place in the company.

In the realm of hedge fund activity related to $BC, significant movement has been observed with 201 institutional investors adding shares to their portfolios, while 195 reduced their positions in the most recent quarter. Noteworthy additions were made by companies like American Century Companies Inc, which acquired 830,451 shares amounting to $52,517,721 and Bank of New York Mellon Corp, which added 700,447 shares valued at $44,296,268. Conversely, Turtle Creek Asset Management Inc. removed 648,394 shares worth $41,004,436 from its portfolio, indicating a diversified activity among hedge funds related to $BC stock.

Regarding revenue performance, $BC reported revenues of $1.3 billion in the fourth quarter of 2025, signaling a notable 15.49% increase compared to the corresponding period in the previous year. This growth in revenue is a positive indicator of the company’s financial health and performance over time.

On the analyst front, Wall Street analysts have been active in issuing reports on $BC, with a notable trend of four firms issuing buy ratings for the stock in recent months. No sell ratings have been reported, signifying a consistent bullish sentiment towards $BC among analysts. These ratings provide insights into the market sentiment and investment recommendations surrounding $BC stock, influencing investor decisions and market behavior.

Multiple analysts have also shared price targets for $BC recently, with 14 analysts offering price estimates in the last six months. The median target price stands at $75.5, reflecting a collective analyst projection regarding the future valuation of $BC stock. These targets, set by various analysts at different times, highlight the range of expectations and predictions regarding the stock’s performance, serving as valuable guidance for investors looking to evaluate their investment strategies.

In conclusion, the recent insider sale, hedge fund activity, revenue performance, analyst ratings, and price targets related to $BC provide a comprehensive overview of the current state of affairs around this particular company in the financial market. These insights serve as essential information for investors and market observers, offering valuable data to inform decision-making processes in the investment landscape.